PubMed=12089864
Roswitha Pfragner, Gerhard Hubert Wirnsberger, Elisabeth Ingolic, Bruno Niederle;
Medullary thyroid carcinomas in cell culture -- models for future therapies.
Wien. Klin. Wochenschr. 114:279-283(2002)

PubMed=15126569; DOI=10.1210/jc.2003-031314
Klaus Kaczirek, Martin Schindl, Andreas Weinhausel, Christian Scheuba, Christian Passler, Gerhard Prager, Markus Raderer, Gerhard Hamilton, Martina Mittlbock, Veronika Siegl, Roswitha Pfragner, Bruno Niederle;
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines.
J. Clin. Endocrinol. Metab. 89:2397-2401(2004)

PubMed=17786610; DOI=10.1080/14653240701385836
Guido Stadler, Matthias Wieser, Franz Steindl, Johannes Grillari, Hermann Katinger, Roswitha Pfragner, Regina Voglauer;
Development of standarDIzed cell culture conditions for tumor cells with potential clinical application.
Cytotherapy 9:488-498(2007)

PubMed=22038905; DOI=10.1002/ijc.26494
Karin Flicker, Peter Ulz, Harald Hoger, Petra Zeitlhofer, Oskar Arthur Haas, Annemarie Behmel, Wolfgang Buchinger, Christian Scheuba, Bruno Niederle, Roswitha Pfragner, Michael R. Speicher;
High-resolution analysis of alterations in medullary thyroid carcinoma genomes.
Int. J. Cancer 131:E66-E73(2012)

CLPUB00412
Zainab Ghazal Siddiqui;
Medullary thyroid cancer: the current state of tumour marker and treatment strategies.
Thesis MD (2015); Medical University of Graz; Graz; Austria